![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1997 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 3,0015% increase | Employees 9,052 |
Valuation ($) | Valuation ($) 13.3 b | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $717.4m (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $2.5b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income $348.9m (FY, 2025) | Net income €1.6b (FY, 2025) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company